Regen BioPharma Inc At Emerging Growth Conference Transcript
Welcome back, everyone. Next, we have Regen Biopharma, Inc. It trades on the OTC Pink Sheets under the symbol RGBP and is a biotechnology company focused on developing innovative treatments using autologous cell therapies, RNA, DNA-based immunotherapy, and small molecules in the immune oncology and autoimmune disease space.
Please welcome, President and CEO, David Koos; as well as Harry Lander, Senior Scientific Consultant. Nice to see you, gentlemen.
Good morning. We're glad to be here this morning, and I'm excited about finally being able to talk about what's going on with the company.
Perfect. Well, the floor is yours. And you know to call me back when you're ready for questions.
Perfect. So I would like to start off this morning, over the last -- I don't know, four
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |